Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.

Fernández L, Carrillo E, Sánchez-Sampedro L, Sánchez C, Ibarra-Meneses AV, Jimenez MA, Almeida VDA, Esteban M, Moreno J.

Front Immunol. 2018 Apr 23;9:843. doi: 10.3389/fimmu.2018.00843. eCollection 2018.

2.

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.

Lázaro-Frías A, Gómez-Medina S, Sánchez-Sampedro L, Ljungberg K, Ustav M, Liljeström P, Muñoz-Fontela C, Esteban M, García-Arriaza J.

J Virol. 2018 May 14;92(11). pii: e00363-18. doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.

3.

NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis.

Sánchez-Sampedro L, Mejías-Pérez E, S Sorzano CÓ, Nájera JL, Esteban M.

Virus Res. 2016 Jul 15;220:1-11. doi: 10.1016/j.virusres.2016.03.007. Epub 2016 Mar 29.

PMID:
27036935
4.

Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression.

Di Pilato M, Sánchez-Sampedro L, Mejías-Pérez E, Sorzano CO, Esteban M.

J Gen Virol. 2015 Aug;96(8):2360-71. doi: 10.1099/vir.0.000183. Epub 2015 May 13.

PMID:
25972354
5.

The evolution of poxvirus vaccines.

Sánchez-Sampedro L, Perdiguero B, Mejías-Pérez E, García-Arriaza J, Di Pilato M, Esteban M.

Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726. Review.

6.

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M.

J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14. Epub 2014 Oct 29.

7.

Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Sánchez-Sampedro L, Gómez CE, Mejías-Pérez E, Pérez-Jiménez E, Oliveros JC, Esteban M.

J Virol. 2013 Jun;87(12):6955-74. doi: 10.1128/JVI.03013-12. Epub 2013 Apr 17.

8.

High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.

Sánchez-Sampedro L, Gómez CE, Mejías-Pérez E, Sorzano CO, Esteban M.

PLoS One. 2012;7(6):e38859. doi: 10.1371/journal.pone.0038859. Epub 2012 Jun 8.

9.

Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Vijayan A, Gómez CE, Espinosa DA, Goodman AG, Sanchez-Sampedro L, Sorzano CO, Zavala F, Esteban M.

J Immunol. 2012 Jun 15;188(12):6407-17. doi: 10.4049/jimmunol.1102492. Epub 2012 May 21.

Supplemental Content

Loading ...
Support Center